SAGES Magazine

u n i q u e 2 p h a s e d r e l e a s e t e c h n o l o g y NEW 2,3 TAKEDA (Pty) Ltd. Reg. No.: 1982/011215/07. Building A, Monte Circle, 64 Montecasino Boulevard, Fourways, 2191, South Africa. Tel: +27 (0) 11 514 3000 . Fax: +27 (0) 11 514 3001. Marketed by Adcock Ingram Healthcare (Pty) Ltd. Reg. No. 2007/019928/07. Private Bag X69, Bryanston, 2021, South Africa. Tel +27 (0) 11 635 0000 . www.adcock.com. C-APROM/ZA/DEXI/0010. The first once-a-day PPI with novel dual delayed release technology 1,2 Coming soon! 24 hour HEARTBURN FREE DAYS are achievable 1,2 PPI = Proton pump inhibitor References: 1. Dexilant Professional Information. Takeda (Pty) Ltd, South Africa; August 2021. 2. Metz DC, Howden CW, Perez MC, et al . Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis. Aliment Pharmacol Ther 2009;29:742-754. At last... a new chemical entity your patients can start on once-daily and stay on once-daily 1,2 Rapid release 1-2 hours Delayed release 4-5 hours 1 capsule daily